Comparative Pharmacology
Head-to-head clinical analysis: NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis, leading to anti-inflammatory, analgesic, and antipyretic effects. Pseudoephedrine hydrochloride is a sympathomimetic amine that acts as a direct and indirect alpha-adrenergic agonist, causing vasoconstriction and decongestion of nasal mucosa.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
One tablet (naproxen sodium 220 mg/pseudoephedrine HCl 120 mg) orally every 12 hours; maximum 2 tablets in 24 hours. For extended-release formulations: one tablet (naproxen sodium 440 mg/pseudoephedrine HCl 240 mg) orally every 12 hours; maximum 2 tablets in 24 hours.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Naproxen: 12-17 hours (terminal), allowing twice-daily dosing; prolonged in elderly or renal impairment. Pseudoephedrine: 4-6 hours (pH-dependent; shorter with acidic urine, prolonged with alkaline urine).
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Naproxen: ~95% renal (primarily as unchanged drug and conjugates), <5% biliary. Pseudoephedrine: 70-90% renal (unchanged), remainder hepatic metabolism.
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category A/B
Category C
Sympathomimetic
Sympathomimetic